Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Advertising & Marketing

Sales

Legal & Regulatory

Acquisition & Integration

Goodwill impairment

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Teladoc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Teladoc reports solid Q4 growth, eyes revenue optimization strategies

Teladoc's Q4 performance showed revenue growth and margin focus, with BetterHelp contributing significantly to profitability.
The company's strategic focus on virtual care expansion and revenue optimization positions Teladoc for continued success in the healthcare market.
While facing internal restructuring challenges, Teladoc's emphasis on growth drivers and operational efficiency presents opportunities for future growth and market leadership.

Teladoc Health excels in Q1, eyes growth and efficiency

Teladoc Health's Q1 performance was strong, with revenue exceeding expectations.
The company is focused on efficiency, innovation, and driving value in virtual care.
BetterHelp segment showed growth and stability, with improving margins expected.
Opportunities exist to capitalize on ad pricing stability and consumer behavior trends.

Teladoc surpasses revenue expectations, focuses on innovation and growth

Teladoc's Q2 performance exceeded expectations, with strong revenue growth and improved margins in both segments. The company's strategic focus on whole-person care, weight management, and AI enhancements positions it well for future growth. Challenges include managing drug costs and private company valuations, while opportunities lie in virtual care demand and strategic M&A.
Teladoc's financial strength, commitment to innovation, and focus on efficiency improvements are key strengths driving its performance. The company's ability to navigate challenges and capitalize on opportunities in the evolving healthcare landscape underscores its resilience and growth potential.

Teladoc Health surpasses Q3 expectations, eyes margin expansion in '24

Teladoc Health's Q3 performance exceeded expectations, driven by revenue growth and margin improvements.
The company is focused on enhancing cost efficiencies, profitability, and driving margin expansion.
Stable pricing environment and strong client demand present opportunities for future growth.
Operational review and strategic initiatives position Teladoc for continued success in the healthcare sector.

Teladoc reports robust 2023 earnings, eyes growth amid marketing challenges

Teladoc delivered strong financial performance in 2023 with notable growth in adjusted EBITDA and revenue. The company faces challenges in BetterHelp marketing yields and delayed consumer engagement efforts.
However, Teladoc's strategic strengths lie in its long-term outlook for revenue growth, margin expansion, and cost-saving initiatives. Opportunities exist in optimizing sales force structure and capital deployment for future growth.
Overall, Teladoc's focus on profitability, growth optimization, and strategic capital allocation positions it well for sustained success in the telehealth industry.

Teladoc Health reports solid Q1 performance amidst revenue challenges

Teladoc Health's Q1 2024 performance showcased revenue growth in Integrated Care but challenges in BetterHelp segment revenue and margin management.
The company's financial strength, product portfolio, and cost initiatives position it well for growth opportunities and strategic market positioning.
Addressing challenges in ad spend management and focusing on international market efficiency are key to unlocking growth potential and improving financial performance.
Overall, Teladoc's performance, strengths, challenges, and opportunities reflect a dynamic landscape with strategic focus on sustainable growth and operational efficiency.

Teladoc Health reports Q2 revenue dip, EBITDA growth; addresses challenges

Teladoc Health's Q2 2024 performance showed mixed results with revenue decline but EBITDA growth. The company is leveraging strengths in patient safety and technology while addressing challenges in customer acquisition costs. Opportunities lie in operational efficiency, insurance coverage access, and international expansion.

Teladoc Health reports Q3 revenue decline but strategic growth

Teladoc Health's Q3 2024 performance reflects mixed results with revenue decline but strategic growth in the Integrated Care segment.
The company's focus on customer-centric strategies, technology, and clinical excellence positions it well for future success and market leadership.
Challenges in revenue decline and expense management require Teladoc Health to balance short-term financial performance with long-term growth objectives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

Teladoc stock was hit previously when Amazon Care announced its nationwide rollout.

Teladoc Stock: Will Amazon's New Telehealth Service Impact Business Outlook?

IntriCon

Eli Lilly

Moderna

Novavax

Do these healthcare stocks pique your interest?

Stocks To Invest In Right Now? 5 Health Care Stocks For Your March Watchlist

Amazon

Teladoc Health (TDOC) collaborates with Amazon so that customers can avail quick and effective virtual care medical services via their Alexa-activated intelligent speakers.

Teladoc Health (TDOC), Amazon Tie Up to Advance Virtual Care

CRISPR Therapeutics

Chevron

Nu Holdings

Vertex Pharmaceuticals

Buffett's latest letter to Berkshire Hathaway shareholders revealed the legendary investor's present mindset.

Should You Buy Stocks Now? Here's What Warren Buffett Thinks

Comments from the earnings call make a compelling case.

This Service Could Be Teladoc's Key to Profitability

Voice is projecting itself deeper into how we monitor health and receive care, as various types of voice technology are vying for the spot in the chorus of treatment modalities. The latest evidence comes from telehealth platform Teladoc, which announced its new integration with Amazon Alexa for “voice-activated general medical virtual care.

Alexa-Teladoc Deal the Latest Shoutout to a Future of Voice-Assisted Healthcare

Virtual care provider Teladoc Heath has launched a collaboration with Amazon Alexa to provide care on Echo devices such the Echo, Echo Dot, and Echo Show. The partnership – announced in a news release Monday (Feb. 28) – will initially involve Teladoc launching on Alexa via audio, with video visits scheduled for the near future.

Teladoc Health Launches Amazon Collaboration

Getting a hold of a doctor when you need one just got easier. On Monday, telehealth services company Teladoc Health Inc. ( TDOC , Financial) announced that it has teamed up with Amazon.com Inc. ( AMZN , Financial)'s Alexa to offer voice-activated virtual care services.

Alexa, I Want to Talk to a Doctor

There are plenty of opportunities on the horizon for the telehealth leader.

Given the Growing List of Positive Catalysts, Is Teladoc Stock Finally a Buy?

Telehealth stock Teladoc Health Inc (NYSE:TDOC) is moving higher, last seen up 8.7% to trade at $76.88.

Call Traders Blast Teladoc Stock on Amazon Partnership

The digital healthcare provider announced a major new collaboration.

Why Teladoc Health Stock Charged Sharply Higher on Monday

TDOC stock has not performed well in 2022. Tougher times may be ahead as revenue growth is expected to slow down even more.

Teladoc Health Is Not a Great Defensive Stock in 2022

If there is no doctor in the house, Amazon's Alexa will soon be able to summon one.

Amazon's voice assistant Alexa to start seeking doctor help

Teladoc Health Inc (NYSE: TDOC) is trading higher Monday after the company announced it teamed up with Amazon.com Inc (NASDAQ: AMZN) to launch Teladoc services on Alexa-enabled devices.  Those with supported Amazon Echo devices will have access to voice-activated general medical.

Why Teladoc Shares Are Trading Higher Today

The telehealth provider says its service on Amazon's Alexa will initially launch via audio, with video visits "coming soon."

Teladoc Health, Amazon Launch Teladoc on Alexa. Teladoc Stock Is Up.

Shares of Teladoc Health Inc. TDOC, +7.93% shot up 12.7% in premarket trading Monday, after the provider of tele-healthcare services said it has teamed up with Amazon.com Inc. AMZN, -0.68% Alexa on voice-activated virtual care services. The service will be available on Amazon Alexa devices, including the Echo, the Echo Dot and Echo Show.

Teladoc stock jumps after teaming up with Amazon Alexa

First of its Kind Alexa Experience Provides Hands-Free Access at Home to General Medical Care First of its Kind Alexa Experience Provides Hands-Free Access at Home to General Medical Care

Teladoc Health and Amazon Team Up to Launch Teladoc on Alexa

Teladoc Health trades back to pre-covid levels despite forecasted strong growth.

Teladoc Health: Buy After COVID-19 Bubble Ends

These Are the 2 Most Important Numbers in Teladoc's Earnings Report

Hims & Hers Health

Novocure

Some popular names in the healthcare sector have been down even by about 50% from their highs recently. But there are lots of opportunities in this sector.

Top 3 Cheap Healthcare Stocks You Shouldn't Ignore.

The business is a lot safer than the stock's movement suggests.

Why Teladoc May Be One of the Best Growth Stocks to Buy in March

After falling 54% in 2021, Teladoc Health (NYSE: TDOC) may be getting a closer look from investors. If it is, investors will find that emotions and facts are lining up quite nicely.

The Facts are Supporting the Justified Enthusiasm for Teladoc Health

This risk has been a concern among investors.

These 18 Words From Teladoc's CEO May Eliminate 1 Big Risk

MicroStrategy Incorporated

NVIDIA

Peloton

Royal Caribbean Cruises

Boston Beer Company

Block

Many stocks that may seem attractive are actually still overvalued. Here are seven stocks to sell before their outlooks dim even further.

7 Overvalued Stocks to Sell While You Still Can

Here's the real scoop about the virtual care leader.

News for Teladoc Stock (TDOC)